These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 836494)

  • 21. Prevention of CeCl3-induced hepatotoxicity by hypolipidemic compounds.
    Tuchweber B; Salas M
    Arch Toxicol; 1978 Dec; 41(3):223-32. PubMed ID: 736793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypolipidemic substituted 1,3-benzodioxole-2-carboxylates.
    Grisar JM; Claxton GP; Parker RA; Palopoli FP; Kariya T
    J Med Chem; 1974 Jul; 17(7):721-5. PubMed ID: 4836402
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on hypolipidemic agents. IV. Syntheses and hypolipidemic activities of 4-substituted phenoxyisobutyric acid derivatives (author's transl)].
    Miyoshi F; Fukami H; Sako Y
    Yakugaku Zasshi; 1974 Sep; 94(9):1061-9. PubMed ID: 4476773
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypolipidemic activity of 5-aryl-3-methylvaleric acid derivatives.
    Dygos JH; Jett CM; Chinn LJ; Miller JE
    J Med Chem; 1977 Dec; 20(12):1705-8. PubMed ID: 592342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel pyrimidine and 1,3,5-triazine hypolipidemic agents.
    d'Atri G; Gomarasca P; Resnati G; Tronconi G; Scolastico C; Sirtori CR
    J Med Chem; 1984 Dec; 27(12):1621-9. PubMed ID: 6502593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
    Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
    Digestion; 1979; 19(4):228-36. PubMed ID: 478204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypolipidemic analogues of ethyl 4-benzyloxybenzoate.
    Baggaley KH; Fears R; Hindley RM; Morgan B; Murrell E; Thorne DE
    J Med Chem; 1977 Nov; 20(11):1388-93. PubMed ID: 915898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
    Ohata I; Sakamoto N; Nitatori R; Maeno H
    Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats.
    Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypolipidemic activity of phthalimide derivatives V: Reduced and hydrolytic products of simple cyclic imides.
    Chapman JM; Wyrick SD; Josée Voorstad P; Maguire JH; Cocolas GH; Hall IH
    J Pharm Sci; 1984 Oct; 73(10):1482-4. PubMed ID: 6502502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
    Chrysselis MC; Rekka EA; Kourounakis PN
    J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newer hypolipidemic compounds.
    Kritchevsky D
    Adv Exp Med Biol; 1975; 63():135-50. PubMed ID: 1106139
    [No Abstract]   [Full Text] [Related]  

  • 33. (Aryloxy)[p-(aryloxy)phenyl]- and (aryloxy)[p-(arylthio)phenyl]acetic acids and esters as hypolipidemic agents.
    Trust RI; McEvoy FJ; Albright JD
    J Med Chem; 1979 Sep; 22(9):1068-74. PubMed ID: 490551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 9-Chloro-2,3-dihydro-5H-1,4-dioxepino(6,5-b)benzofuran, a novel antilipidemic agent structurally related to clofibrate.
    Witiak DT; Poochikian GK; Feller DR; Kenfield NA; Newman HA
    J Med Chem; 1975 Oct; 18(10):992-6. PubMed ID: 1159693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypolipidemic imidazoles.
    Baggaley KH; Heald M; Hindley RM; Morgan B; Tee JL; Green J
    J Med Chem; 1975 Aug; 18(8):833-6. PubMed ID: 1159701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on antihyperlipidemic agents. I. Synthesis and hypolipidemic activities of phenoxyphenyl alkanoic acid derivatives.
    Kawamatsu Y; Saraie T; Imamiya E; Nishikawa K; Hamuro Y
    Arzneimittelforschung; 1980; 30(3):454-9. PubMed ID: 7387754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR; Kelly LA; Ho RS; Trapold JH
    Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypolipidemic activity of some derivatives of 6H-dibenzo[b,d]pyran.
    Banzatti C; Branzoli U; Lovisolo PP; Melloni P; Orsini G; Salvadori P
    Arzneimittelforschung; 1984; 34(8):864-9. PubMed ID: 6541922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of ethyl 2-(4-chlorophenyl)-5-(2-furyl)-4-oxazoleacetate, a hypolipidemic agent, and related compounds.
    Moriya T; Seki M; Takabe S; Matsumoto K; Takashima K; Mori T; Odawara A; Takeyama S
    J Med Chem; 1988 Jun; 31(6):1197-204. PubMed ID: 3373489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antilipidemic agents, Part. IV: Synthesis and antilipidemic testing of some heterocyclic derivatives of hexadecyl and cyclohexyl hemisuccinate esters.
    Habib NS; Ismail KA; el-Tombary AA; Abdel Aziem T
    Pharmazie; 2000 Jul; 55(7):495-9. PubMed ID: 10944775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.